Top Markets
Coin of the day
Response Genetics, Inc Response Genetics, Inc

Response Genetics, Inc

RGDXQ
Classement en actions #42156
Response Genetics, Inc., a life sciences company founded in Los Angeles,... Response Genetics, Inc., a life sciences company founded in Los Angeles, California, in 1999 (originally Bio Type, Inc., before its rebranding in August 2000), focuses on creating, advancing, and commercializing pharmacogenomic tests. These diagnostic tools are crucial for informing cancer treatment decisions by assessing specific indicators within tumor tissue samples that predict a patient's response to therapy. The company provides an extensive array of testing services, primarily through its ResponseDX suite, covering various cancers such as non-small cell lung, colorectal, gastric, gastroesophageal, melanoma, thyroid, breast, and glioma, in addition to a Tissue of Origin test. Beyond these existing solutions, Response Genetics is committed to expanding its diagnostic offerings to encompass other tumor types, while also delivering both the technical execution and professional interpretation components of its testing services. Operating globally, with a significant presence in the United States and Europe, Response Genetics serves a wide range of clients including community oncologists, pathologists, medical practices, hospitals, and pharmaceutical enterprises, primarily through its internal sales force.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$3.87K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Response Genetics, Inc (RGDXQ)

Catégorie

Le prix RGDXQ avec la capitalisation boursière de B
Response Genetics, Inc Response Genetics, Inc
RGDXQ
$0.0001
Capitalisation boursière de Response Genetics, Inc(RGDXQ)
Capitalisation boursière: $3.87K
En August 2026, Response Genetics, Inc a une capitalisation boursière de $3.87K. Cela fait de Response Genetics, Inc la 42156th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Response Genetics, Inc du 2007 au 2026
RGDXQ par rapport au top 5 des plus populaires stocks
Prix pour RGDXQ L’actif B La capitalisation boursière de B Résultats
Response Genetics, Inc Response Genetics, Inc
$138,997 $3.87K
$5.383T +138,997,145,781.75%
Response Genetics, Inc Response Genetics, Inc
$114,211 $3.87K
$4.423T +114,210,978,566.10%
Response Genetics, Inc Response Genetics, Inc
$107,420 $3.87K
$4.160T +107,419,813,973.90%
Response Genetics, Inc Response Genetics, Inc
$94,586.13 $3.87K
$3.663T +94,586,130,470.62%
Response Genetics, Inc Response Genetics, Inc
$74,650.89 $3.87K
$2.891T +74,650,885,399.61%